The presence of activated CD4+ and CD8+ T cells in CRC patients has been closely linked to effective antitumor immunity [59, 60], while follicular helper T cells are also associated with improved survival outcomes in CRC [61]. Here, CD8A is linked to colorectal carcinoma.